KRYS · Company research
Krystal Biotech, Inc. Common Stock (KRYS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 324.57 | $10,333,861,560 | 9906121560.00 | 188.3128491620111732 | — | 4.8584715083798877 | — | 7.6033138649396745 | 145.0895984499606889 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.